BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 34674998)

  • 1. Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups.
    Sabin ND; Hwang SN; Klimo P; Chambwe N; Tatevossian RG; Patni T; Li Y; Boop FA; Anderson E; Gajjar A; Merchant TE; Ellison DW
    AJNR Am J Neuroradiol; 2021 Dec; 42(12):2245-2250. PubMed ID: 34674998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging features to distinguish posterior fossa ependymoma subgroups.
    Leclerc T; Levy R; Tauziède-Espariat A; Roux CJ; Beccaria K; Blauwblomme T; Puget S; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Bolle S; Roux A; Pallud J; Provost C; Oppenheim C; Varlet P; Boddaert N; Dangouloff-Ros V
    Eur Radiol; 2024 Mar; 34(3):1534-1544. PubMed ID: 37658900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
    Michealraj KA; Kumar SA; Kim LJY; Cavalli FMG; Przelicki D; Wojcik JB; Delaidelli A; Bajic A; Saulnier O; MacLeod G; Vellanki RN; Vladoiu MC; Guilhamon P; Ong W; Lee JJY; Jiang Y; Holgado BL; Rasnitsyn A; Malik AA; Tsai R; Richman CM; Juraschka K; Haapasalo J; Wang EY; De Antonellis P; Suzuki H; Farooq H; Balin P; Kharas K; Van Ommeren R; Sirbu O; Rastan A; Krumholtz SL; Ly M; Ahmadi M; Deblois G; Srikanthan D; Luu B; Loukides J; Wu X; Garzia L; Ramaswamy V; Kanshin E; Sánchez-Osuna M; El-Hamamy I; Coutinho FJ; Prinos P; Singh S; Donovan LK; Daniels C; Schramek D; Tyers M; Weiss S; Stein LD; Lupien M; Wouters BG; Garcia BA; Arrowsmith CH; Sorensen PH; Angers S; Jabado N; Dirks PB; Mack SC; Agnihotri S; Rich JN; Taylor MD
    Cell; 2020 Jun; 181(6):1329-1345.e24. PubMed ID: 32445698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymal Tumors: Overview of the Recent World Health Organization Histopathologic and Genetic Updates with an Imaging Characteristic.
    Soni N; Ora M; Bathla G; Desai A; Gupta V; Agarwal A
    AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial ependymomas: molecular insights and translation to treatment.
    Lester A; McDonald KL
    Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fully Automated Deep-Learning Model for Predicting the Molecular Subtypes of Posterior Fossa Ependymomas Using T2-Weighted Images.
    Cheng D; Zhuo Z; Du J; Weng J; Zhang C; Duan Y; Sun T; Wu M; Guo M; Hua T; Jin Y; Peng B; Li Z; Zhu M; Imami M; Bettegowda C; Sair H; Bai HX; Barkhof F; Liu X; Liu Y
    Clin Cancer Res; 2024 Jan; 30(1):150-158. PubMed ID: 37916978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas.
    Pohl LC; Leitheiser M; Obrecht D; Schweizer L; Wefers AK; Eckhardt A; Raffeld M; Sturm D; Pajtler KW; Rutkowski S; Fukuoka K; Ichimura K; Bockmayr M; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):24. PubMed ID: 38265522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Soap bubble" sign as an imaging marker for posterior fossa ependymoma Group B.
    Jin Y; Cheng D; Duan Y; Zhuo Z; Weng J; Zhang C; Zhu M; Liu X; Du J; Hua T; Li H; Haller S; Barkhof F; Liu Y
    Neuroradiology; 2023 Dec; 65(12):1707-1714. PubMed ID: 37837480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
    Donson AM; Bertrand KC; Riemondy KA; Gao D; Zhuang Y; Sanford B; Norris GA; Chapman RJ; Fu R; Willard N; Griesinger AM; Ribeiro de Sousa G; Amani V; Grimaldo E; Hankinson TC; Booker F; Sill M; Grundy RG; Pajtler KW; Ellison DW; Foreman NK; Ritzmann TA
    Neuro Oncol; 2023 Oct; 25(10):1854-1867. PubMed ID: 37246777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
    Griesinger AM; Calzadilla AJ; Grimaldo E; Donson AM; Amani V; Pierce AM; Steiner J; Kargar S; Serkova NJ; Bertrand KC; Wright KD; Vibhakar R; Hankinson T; Handler M; Lindsay HB; Foreman NK; Dorris K
    Clin Cancer Res; 2024 Apr; 30(8):1544-1554. PubMed ID: 38334950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.
    Gödicke S; Kresbach C; Ehlert M; Obrecht D; Altendorf L; Hack K; von Hoff K; Carén H; Melcher V; Kerl K; Englinger B; Filbin M; Pajtler KW; Gojo J; Pietsch T; Rutkowski S; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):23. PubMed ID: 38265527
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Whitehouse JP; Hii H; Mayoh C; Wong M; Ajuyah P; Barahona P; Cui L; Dholaria H; White CL; Buntine MK; Byrne J; Rodrigues da Silva K; Howlett M; Girard EJ; Tsoli M; Ziegler DS; Dyke JM; Lee S; Ekert PG; Cowley MJ; Gottardo NG; Endersby R
    Front Oncol; 2023; 13():1123492. PubMed ID: 36937401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.
    Panwalkar P; Tamrazi B; Dang D; Chung C; Sweha S; Natarajan SK; Pun M; Bayliss J; Ogrodzinski MP; Pratt D; Mullan B; Hawes D; Yang F; Lu C; Sabari BR; Achreja A; Heon J; Animasahun O; Cieslik M; Dunham C; Yip S; Hukin J; Phillips JJ; Bornhorst M; Griesinger AM; Donson AM; Foreman NK; Garton HJL; Heth J; Muraszko K; Nazarian J; Koschmann C; Jiang L; Filbin MG; Nagrath D; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Allis CD; Chinnaiyan AM; Lunt SY; Blüml S; Judkins AR; Venneti S
    Sci Transl Med; 2021 Oct; 13(614):eabc0497. PubMed ID: 34613815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed radiation-induced cerebral vasculopathy mimicking tumour in an adolescent 14 years after radiation therapy for posterior fossa ependymoma.
    Kung MS; Navalkele P; Crawford JR
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719251
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: Impact of Molecular Subgroups on Prognosis and Survival Outcomes in Posterior Fossa Ependymomas: A Retrospective Study of 412 Cases.
    Lampros M; Voulgaris S; Alexiou GA
    Neurosurgery; 2024 Apr; ():. PubMed ID: 38619273
    [No Abstract]   [Full Text] [Related]  

  • 16. Have the cake and eat it too: PFA, a case of a technological miracle?
    Avitall B
    J Cardiovasc Electrophysiol; 2024 Jan; 35(1):94-96. PubMed ID: 38031813
    [No Abstract]   [Full Text] [Related]  

  • 17. EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
    Jenseit A; Camgöz A; Pfister SM; Kool M
    Acta Neuropathol; 2022 Jan; 143(1):1-13. PubMed ID: 34762160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral-type posterior fossa ependymomas in pediatric patients: a national collaborative study.
    Miranda-Lloret P; Plaza-Ramírez E; López-Guerrero A; López-Bermeo D; García-Campos T; Vázquez-Sufuentes S; Munárriz PM; López-García E; Londoño-Quiroz A; Ferreras-García C; García-Conde M; Saceda-Gutiérrez J; Giménez-Pando J; Pancucci G; Iglesias-Moroño S
    Childs Nerv Syst; 2024 Feb; 40(2):407-416. PubMed ID: 37889277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly Recognized CNS Tumors in the 2021 World Health Organization Classification: Imaging Overview with Histopathologic and Genetic Correlation.
    Rigsby RK; Brahmbhatt P; Desai AB; Bathla G; Ebner BA; Gupta V; Vibhute P; Agarwal AK
    AJNR Am J Neuroradiol; 2023 Apr; 44(4):367-380. PubMed ID: 36997287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.